Cargando…
A real-life comparison of pulmonary and nasal outcomes in patients with severe asthma and nasal polyposis treated with T2-biologics
BACKGROUND: Severe asthma (SA) with comorbid chronic rhinosinusitis with nasal polyps (CRSwNP) is frequently associated with type 2 (T2) inflammatory endotype. Consequently, therapeutic targets are T2 biologics. The present retrospective study aimed to analyze and compare the clinical efficacy of me...
Autores principales: | Förster-Ruhrmann, Ulrike, Stergioudi, Dafni, Szczepek, Agnieszka J., Fluhr, Joachim W., Zuberbier, Torsten, Olze, Heidi, Bergmann, Karl-Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9958493/ https://www.ncbi.nlm.nih.gov/pubmed/36852411 http://dx.doi.org/10.1016/j.waojou.2023.100746 |
Ejemplares similares
-
COVID-19 in a patient with severe chronic rhinosinusitis with nasal polyps during therapy with dupilumab
por: Förster-Ruhrmann, Ulrike, et al.
Publicado: (2020) -
Omalizumab is effective in nasal polyposis with or without asthma, a real-life study
por: Tat, Tuğba Songül
Publicado: (2022) -
Chemokine Expression-Based Endotype Clustering of Chronic Rhinosinusitis
por: Förster-Ruhrmann, Ulrike, et al.
Publicado: (2022) -
Can nasal acetylsalicylic acid challenge predict the severity of non-steroidal anti-inflammatory drugs (NSAIDs)-exacerbated respiratory disease (N-ERD)?
por: Förster-Ruhrmann, Ulrike, et al.
Publicado: (2020) -
Extension of mepolizumab injection intervals as potential of saving costs in well controlled patients with severe eosinophilic asthma()()
por: Bölke, Georg, et al.
Publicado: (2022)